Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer.

Transl Oncol · 2015 · PMC4562974 · PMID 26310375

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In subgroup analyses, women, but not men, showed a trend toward poorer prognosis for DFS and OS in the subset of patients with IGFBP-3 methylation as compared with those without IGFBP-3 methylation (8-year DFS: 55.6% vs 71.6%, P = .3694 and 8-year OS: 55.6% vs 68.4%, P = .491, respectively; Figure 3 ) even with no statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.